62 related articles for article (PubMed ID: 24599349)
1. Resveratrol down-regulates a glutamate-induced tissue plasminogen activator via Erk and AMPK/mTOR pathways in rat primary cortical neurons.
Cho KS; Lee EJ; Kwon KJ; Gonzales EL; Kim YB; Cheong JH; Bahn GH; Lee J; Han SH; Kim YT; Shin CY
Food Funct; 2014 May; 5(5):951-60. PubMed ID: 24599349
[TBL] [Abstract][Full Text] [Related]
2. Tissue-type plasminogen activator protects neurons from excitotoxin-induced cell death via activation of the ERK1/2-CREB-ATF3 signaling pathway.
Wu F; Echeverry R; Wu J; An J; Haile WB; Cooper DS; Catano M; Yepes M
Mol Cell Neurosci; 2013 Jan; 52():9-19. PubMed ID: 23063501
[TBL] [Abstract][Full Text] [Related]
3. Identification of regulated proteins by resveratrol in glutamate-induced cortical injury of newborn rats.
Gim SA; Park DJ; Kang JB; Shah FA; Koh PO
J Vet Med Sci; 2021 Apr; 83(4):724-733. PubMed ID: 33716268
[TBL] [Abstract][Full Text] [Related]
4. Tissue-type plasminogen activator has a neuroprotective effect in the ischemic brain mediated by neuronal TNF-α.
Haile WB; Wu J; Echeverry R; Wu F; An J; Yepes M
J Cereb Blood Flow Metab; 2012 Jan; 32(1):57-69. PubMed ID: 21792242
[TBL] [Abstract][Full Text] [Related]
5. Ythdf2-mediated STK11 mRNA decay supports myogenesis by inhibiting the AMPK/mTOR pathway.
Deng K; Liu Z; Li X; Ren C; Fan Y; Guo J; Li P; Deng M; Xue G; Yu X; Shi J; Zhang Y; Wang F
Int J Biol Macromol; 2024 Jan; 254(Pt 1):127614. PubMed ID: 37884231
[TBL] [Abstract][Full Text] [Related]
6. tPA Modulation of the Blood-Brain Barrier: A Unifying Explanation for the Pleiotropic Effects of tPA in the CNS.
Fredriksson L; Lawrence DA; Medcalf RL
Semin Thromb Hemost; 2017 Mar; 43(2):154-168. PubMed ID: 27677179
[TBL] [Abstract][Full Text] [Related]
7. Effects of Resveratrol, Lovastatin and the mTOR-Inhibitor RAD-001 on Insulin-Induced Genomic Damage In Vitro.
Awad E; Othman EM; Stopper H
Molecules; 2017 Dec; 22(12):. PubMed ID: 29231877
[TBL] [Abstract][Full Text] [Related]
8. The Janus face of endogenous neuronal tPA: promoting self-protection and worsening the death of neighboring neurons.
Prunotto P; Marie P; Lebouvier L; Hommet Y; Vivien D; Ali C
Cell Death Dis; 2024 Apr; 15(4):261. PubMed ID: 38609369
[TBL] [Abstract][Full Text] [Related]
9. The role of resveratrol as a natural modulator in glia activation in experimental models of stroke.
Ghazavi H; Shirzad S; Forouzanfar F; Sahab Negah S; Riyahi Rad M; Vafaee F
Avicenna J Phytomed; 2020; 10(6):557-573. PubMed ID: 33299813
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol triggers autophagy-related apoptosis to inhibit the progression of colorectal cancer via inhibition of FOXQ1.
Zhou M; Niu H; Cui D; Huang G; Li J; Tian H; Xu X; Liang F; Chen R
Phytother Res; 2024 Apr; ():. PubMed ID: 38682953
[TBL] [Abstract][Full Text] [Related]
11. A mechanistic insight into the anticancer potentials of resveratrol: Current perspectives.
Bhuia MS; Chowdhury R; Akter MA; Ali MA; Afroz M; Akbor MS; Sonia FA; Mubarak MS; Islam MT
Phytother Res; 2024 May; ():. PubMed ID: 38768953
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol in Autism Spectrum Disorders: Behavioral and Molecular Effects.
Malaguarnera M; Khan H; Cauli O
Antioxidants (Basel); 2020 Feb; 9(3):. PubMed ID: 32106489
[TBL] [Abstract][Full Text] [Related]
13. P53-induced GAP-43 Upregulation in Primary Cortical Neurons of Rats.
Li T; Jia Y; Fu J; Fu Z; Qiao Z; Liu X; Lv T; Tang R; Yang G
Protein Pept Lett; 2024 Jan; ():. PubMed ID: 38288820
[TBL] [Abstract][Full Text] [Related]
14. Metformin suppresses CYP1A1 and CYP1B1 expression in breast cancer cells by down-regulating aryl hydrocarbon receptor expression.
Do MT; Kim HG; Tran TT; Khanal T; Choi JH; Chung YC; Jeong TC; Jeong HG
Toxicol Appl Pharmacol; 2014 Oct; 280(1):138-48. PubMed ID: 25110054
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotection of resveratrol against cadmium-poisoning acts through dual inhibition of mTORC1/2 signaling.
Liu C; Zhang R; Yang L; Ji T; Zhu C; Liu B; Zhang H; Xu C; Zhang N; Huang S; Chen L
Neuropharmacology; 2022 Nov; 219():109236. PubMed ID: 36049535
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Potential of Polyphenols in the Management of Diabetic Neuropathy.
Kabir MT; Tabassum N; Uddin MS; Aziz F; Behl T; Mathew B; Rahman MH; Akter R; Rauf A; Aleya L
Evid Based Complement Alternat Med; 2021; 2021():9940169. PubMed ID: 34093722
[TBL] [Abstract][Full Text] [Related]
17. Polyphenols for diabetes associated neuropathy: Pharmacological targets and clinical perspective.
Naseri R; Farzaei F; Fakhri S; El-Senduny FF; Altouhamy M; Bahramsoltani R; Ebrahimi F; Rahimi R; Farzaei MH
Daru; 2019 Dec; 27(2):781-798. PubMed ID: 31352568
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol: Twenty Years of Growth, Development and Controversy.
Pezzuto JM
Biomol Ther (Seoul); 2019 Jan; 27(1):1-14. PubMed ID: 30332889
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol ameliorates autophagic flux to promote functional recovery in rats after spinal cord injury.
Wang P; Jiang L; Zhou N; Zhou H; Liu H; Zhao W; Zhang H; Zhang X; Hu Z
Oncotarget; 2018 Feb; 9(9):8427-8440. PubMed ID: 29492205
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol prevents cadmium activation of Erk1/2 and JNK pathways from neuronal cell death via protein phosphatases 2A and 5.
Liu C; Zhang R; Sun C; Zhang H; Xu C; Liu W; Gao W; Huang S; Chen L
J Neurochem; 2015 Nov; 135(3):466-78. PubMed ID: 26146868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
